Bausch + Lomb Announces 24-Month Results From Pivotal US Trial of ELIOS System For Elevated Intraocular Pressure In Open Angle Glaucoma Patients, Meeting Primary Effectiveness Endpoints - Bausch & Lomb (NYSE:BLCO)
Published on March 23, 2026.
The results of a 24-month trial of the ELIOS System for Elevated Intraocular Pressure (ENS) were announced, meeting primary effectiveness objectives of the study. The study also found that the system successfully navigated through the eyes of a patient who was diagnosed with the disease.
Read Original Article